NHS reforms

Publish date:

What next for the pharmaceutical industry? Among other changes implied by the UK government’s NHS reforms, prescribing will be more tightly controlled than ever; responsibility for public health will increasingly be with local government; and commissioning consortia will further alter the stakeholder landscape. The pharma industry needs to get ready by adjusting its commercial model. […]

What next for the pharmaceutical industry?

Among other changes implied by the UK government’s NHS reforms, prescribing will be more tightly controlled than ever; responsibility for public health will increasingly be with local government; and commissioning consortia will further alter the stakeholder landscape. The pharma industry needs to get ready by adjusting its commercial model.

Mike Sobanja, Chief Executive, NHS Alliance, shares his views with Capgemini’s Mark Holliday.

NHS_reforms.pdf

File size: 2.08 MB File type: PDF

Related Resources

The secret to scaling Artificial Intelligence

Tune in to our podcast for a glimpse into where AI is today and how far it might take us...

Balance by Design

Among this time of disruption and discontinuity, ‘Balance by design’ aims to help...

We Collaborate

It’s time to tap into the phenomenal power of the collaborative Technology Business, even as...